Garantie de satisfaction à 100% Disponible immédiatement après paiement En ligne et en PDF Tu n'es attaché à rien
Recherché précédemment par vous
ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY CERTIFICATION | FUNDAMENTALS OF CHEMOTHERAPY IMMUNOTHERAPY EXAM 2024 | ALL ACTUAL EXAM VERSIONS 2024 AND A STUDY GUIDE | ACCURATE AND VERIFIED FOR GUARANTEED PASS | GRADED A | LATEST UPDATE20,16 €
Ajouter au panier
ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY CERTIFICATION | FUNDAMENTALS OF CHEMOTHERAPY IMMUNOTHERAPY EXAM 2024 | ALL ACTUAL EXAM VERSIONS 2024 AND A STUDY GUIDE | ACCURATE AND VERIFIED FOR GUARANTEED PASS | GRADED A | LATEST UPDATE
ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY
CERTIFICATION | FUNDAMENTALS OF CHEMOTHERAPY
IMMUNOTHERAPY EXAM 2024 | ALL ACTUAL EXAM
VERSIONS 2024 AND A STUDY GUIDE | ACCURATE AND
VERIFIED FOR GUARANTEED PASS | GRADED A | LATEST
UPDATE
ONS/ONCC CHEMOTHERAPY IMMUNOTHERAPY CERTIFICATION | FUNDAMENTALS OF CHEMOTHERAPY IMMUNOTHERAPY EXAM 2024 | ALL ACTUAL EXAM VERSIONS 2024 AND A STUDY GUIDE | ACCURATE AND VERIFIED FOR GUARANTEED PASS | GRADED A | LATEST UPDATE A patient reports pain unrelieved by oxycodone. The initial for the nurse is to: A. Request an order for additional medication B. Consult with palliative care services C. Report it to the prescribing physician D. Assess the discomfort in 30 minutes C. Repo rt it to the prescribing physician A patient is scheduled to receive melphalan 140 mg/m2. The patient's measurements are as follows: height 173 cm and weight 85 kg. Using the Mosteller formula, what is the dose to be administered? A. 257 mg B. 283 mg C. 29 5 mg D. 280 mg B. 283 mg Which of the following is an example of a passive immunotherapy agent? A. Trastuzumab* B. Sipuleucel -T C. Melphalan D. Cladribine A. Trastuzumab Which of the following is a characteristic of a cancer cell. A. Restricted movement B. Orderly arrangement C. Uncontrolled division D. Sustained apoptosis C. Uncontrolled division What is the common term for cytokine release syndrome? A. Angiogenic event B. Cell signaling C. Infusion reaction D. Cell apoptosis C. Infusion reaction Which statement made by a patient ordered high dose melphalan shows an understanding of the provided teaching? A. "I should avoid sun exposure." B. "I know that this medication causes constipation." C. "I should empty my bladder frequently." D. I should su ck on ice during administration."* D. I should suck on ice during administration."* Which of the following hormonal agents is classified as an aromatase inhibitor? A. Flutamide B. Leuprolide C. Tamoxifen D. Exemestane* D. Exemestane* A patient scheduled fo r a second dose of flourouracil reports reddening of the skin on the arms, face and neck after gardening. The nurses best response is to: A. Encourage the use of sunscreen when outside B. Withhold the chemotherapy and call the oncologist* C. Instruct on ta king cool showers and baths D. Reassure that these symptoms are expected A. Encourage the use of sunscreen when outside A patient who completed a third cycle of trastuzumab, doxorubicin, cyclophosphamide, and paclitaxel reports numbness and tingling of han ds and feet. Which medication is most likely the cause of this side effect? A. Cyclophosphamide B. Trastuzumab C. Paclitaxel* D. Doxorubicin C. Paclitaxel* To help prevent dose -limiting myelosuppression, give paclitaxel before: A. Antitumor antibodies B. A ntimetabolites C. Alkylating agents* D. Vinca Alkaloids C. Alkylating agents* Which of the following medications is a non -anthracycline antitumor antibiotic? A. Daunorubicin B. Idarubicin C. Mitomycin -C D. Epirubicin C. Mitomycin -C A patient with acute mye loid leukemia begins induction therapy that consists of daily daunorubicin for three days and continuous cytarabine for seven days. On day two, midostaurin is prescribed. What likely precipitated this new order? A. A final cytology report was positive for FLT3 mutation* B. The patient has developed a secondary malignancy. C. The patient missed the second dose of daunorubicin. D. The blast percentage remains high on a peripheral smear. A. A final cytology report was positive for FLT3 mutation* A monoclonal antibody that targets angiogenesis is ordered for a patient with lung cancer. The patient is most likely being treated with: A. Vandetanib B. Bevacizumab* C. Cetuximab D. pazopanib B. Bevacizumab Which agent potentiates cardiotoxicity when adm inistered with trastuzumab? A. Daunorubicin* B. Gemcitabine C. Carmustine D. Bleomycin A. Daunorubicin Fulvestrant dosing includes A. a 20 mg tablet once per day B. two intramuscular injections every four weeks.* C. A subcutaneous injection every four weeks. D. a 400 mg tablet three times a day B. two intramuscular injections every four weeks.* Which statement best describes the mechanism of action of targeted anticancer therapy? A. Block cancer cell proliferation causing cytotoxicity of cancer cells.* B. Act on rapidly dividing cells, which causes an increase in cell death. C. Interfere with specific pathways on or within the cancer cell. D. Selectively target DNA and cell division mechanisms. C. Interfere with spe cific pathways on or within the cancer cell.
Les avantages d'acheter des résumés chez Stuvia:
Qualité garantie par les avis des clients
Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.
L’achat facile et rapide
Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.
Focus sur l’essentiel
Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.
Foire aux questions
Qu'est-ce que j'obtiens en achetant ce document ?
Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.
Garantie de remboursement : comment ça marche ?
Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.
Auprès de qui est-ce que j'achète ce résumé ?
Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur DrMedinaReed. Stuvia facilite les paiements au vendeur.
Est-ce que j'aurai un abonnement?
Non, vous n'achetez ce résumé que pour 20,16 €. Vous n'êtes lié à rien après votre achat.
